Please assess the completion status of the following clinical trial:

Trial Title: Donors After Circulatory Death Heart Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Donor Inclusion~* Maastricht Category III DCD donor, defined as expected death after the withdrawal of life- supportive therapy (WLST)~* Donor age 18-49 years old inclusive~* Warm ischemic time (WIT) ≤ 30 mins, with warm ischemic time defined as: Time from when mean systolic blood pressure (SBP) is \< 50 mmHg or peripheral saturation \< 70% to aortic cross-clamp and administration of cold cardioplegia in the donor.~Donor Exclusion~* Previous cardiac surgery~* Known coronary artery disease~* Cardiogenic shock or myocardial infarction, or~* Sustained terminal ejection fraction (EF) of ≤ 50%, or~* Significant valve disease except for competent bicuspid aortic valve~Recipient Inclusion~* Primary heart transplant candidates~* Age ≥ 18 years old~* Signed: (1) written informed consent document; (2) authorization to use and disclose protected health information; and (3) consent to TransMedics' use of recipients' United Network for Organ Sharing (UNOS)/Organ Procurement and Transplantation Network (OPTN) data and recipients' Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) data.~Recipient Exclusion~* Prior solid organ or bone marrow transplant~* Chronic use of hemodialysis or diagnosis of chronic renal insufficiency~* Multi-organ transplant~* Investigator unwilling to randomize to either arm.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- DCD Heart Possible (Type: EXPERIMENTAL): None
- Standard of Care Heart Only (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).